产品简要
公司名称 :
赛默飞世尔
其他品牌 :
NeoMarkers, Lab Vision, Endogen, Pierce, BioSource International, Zymed Laboratories, Caltag, Molecular Probes, Research Genetics, Life Technologies, Applied Biosystems, GIBCO BRL, ABgene, Dynal, Affinity BioReagents, Nunc, Invitrogen, NatuTec, Oxoid, Richard-Allan Scientific, Arcturus, Perseptive Biosystems, Proxeon, eBioscience
产品类型 :
抗体
产品名称 :
孕酮受体单克隆抗体(SP2)
目录 :
MA5-14505
规格 :
500微升
价格 :
美国792.00
克隆性 :
单克隆
宿主 :
domestic rabbit
共轭标签 :
未共轭
克隆名称 :
SP2
反应物种 :
人类, 小鼠, 大鼠,
应用 :
免疫印迹, 免疫组化, 免疫细胞化学, 流式细胞仪, 染色质免疫沉淀 , 免疫组化-石蜡切片, 免疫组化-冰冻切片
更多信息或购买 :
文章摘录数: 138
出版应用/物种/样本/稀释参考文献
  • 免疫组化-冰冻切片; 小鼠; 1:200; 图 5c
Lozzi B, Huang T, Sardar D, Huang A, Deneen B. Regionally Distinct Astrocytes Display Unique Transcription Factor Profiles in the Adult Brain. Front Neurosci. 2020;14:61 pubmed 出版商
  • 免疫组化-石蜡切片; 小鼠; 图 1b
Sheen M, Marotti J, Allegrezza M, Rutkowski M, Conejo Garcia J, Fiering S. Constitutively activated PI3K accelerates tumor initiation and modifies histopathology of breast cancer. Oncogenesis. 2016;5:e267 pubmed 出版商
  • 免疫组化-石蜡切片; 人类; 1:250; 表 1
Liu Y, Wang K, Xing H, Zhai X, Wang L, Wang W. Attempt towards a novel classification of triple-negative breast cancer using immunohistochemical markers. Oncol Lett. 2016;12:1240-1256 pubmed
  • 免疫组化-石蜡切片; 人类; 1:200; 图 4a
Choi Y, Kim H, Lim E, Park M, Yoon J, Kim Y, et al. Integrative Analyses of Uterine Transcriptome and MicroRNAome Reveal Compromised LIF-STAT3 Signaling and Progesterone Response in the Endometrium of Patients with Recurrent/Repeated Implantation Failure (RIF). PLoS ONE. 2016;11:e0157696 pubmed 出版商
  • 免疫组化; 人类; 1:300
Matsumoto H, Thike A, Li H, Yeong J, Koo S, Dent R, et al. Increased CD4 and CD8-positive T cell infiltrate signifies good prognosis in a subset of triple-negative breast cancer. Breast Cancer Res Treat. 2016;156:237-47 pubmed 出版商
  • 免疫组化-石蜡切片; 人类; 1:200; 表 1
El Gendi S, Mostafa M. Runx2 Expression as a Potential Prognostic Marker in Invasive Ductal Breast Carcinoma. Pathol Oncol Res. 2016;22:461-70 pubmed 出版商
  • 免疫细胞化学; 人类; 1:10; 图 1b
Fridriksdottir A, Kim J, Villadsen R, Klitgaard M, Hopkinson B, Petersen O, et al. Propagation of oestrogen receptor-positive and oestrogen-responsive normal human breast cells in culture. Nat Commun. 2015;6:8786 pubmed 出版商
  • 免疫组化; 人类; 1:1000; 图 6
Ertoy Baydar D, Kosemehmetoglu K, Aydin O, Bridge J, Buyukeren B, Aki F. Primary sclerosing epithelioid fibrosarcoma of kidney with variant histomorphologic features: report of 2 cases and review of the literature. Diagn Pathol. 2015;10:186 pubmed 出版商
  • 免疫组化; 人类; 1:100
KapucuoÄŸlu N, Bozkurt K, BaÅŸpınar Å, Koçer M, EroÄŸlu H, Akdeniz R, et al. The clinicopathological and prognostic significance of CD24, CD44, CD133, ALDH1 expressions in invasive ductal carcinoma of the breast: CD44/CD24 expression in breast cancer. Pathol Res Pract. 2015;211:740-7 pubmed 出版商
  • 免疫印迹; 小鼠; 1:200
Koren S, Reavie L, Couto J, De Silva D, Stadler M, Roloff T, et al. PIK3CA(H1047R) induces multipotency and multi-lineage mammary tumours. Nature. 2015;525:114-8 pubmed 出版商
  • 免疫组化-石蜡切片; 人类; 1:200; 表 2
Cheung S, Boey Y, Koh V, Thike A, Lim J, Iqbal J, et al. Role of epithelial-mesenchymal transition markers in triple-negative breast cancer. Breast Cancer Res Treat. 2015;152:489-98 pubmed 出版商
  • 免疫组化-石蜡切片; 人类; 1:200
Koh V, Lim J, Thike A, Cheok P, Thu M, Tan V, et al. Characteristics and behaviour of screen-detected ductal carcinoma in situ of the breast: comparison with symptomatic patients. Breast Cancer Res Treat. 2015;152:293-304 pubmed 出版商
  • 免疫组化-石蜡切片; 人类
Nwafor C, Keshinro S. Pattern of hormone receptors and human epidermal growth factor receptor 2 status in sub-Saharan breast cancer cases: Private practice experience. Niger J Clin Pract. 2015;18:553-8 pubmed 出版商
  • 免疫组化; 人类; 1:200
Oon M, Thike A, Tan S, Tan P. Cancer stem cell and epithelial-mesenchymal transition markers predict worse outcome in metaplastic carcinoma of the breast. Breast Cancer Res Treat. 2015;150:31-41 pubmed 出版商
  • 免疫印迹; 人类; 图 3
Hole S, Pedersen A, Hansen S, Lundqvist J, Yde C, Lykkesfeldt A. New cell culture model for aromatase inhibitor-resistant breast cancer shows sensitivity to fulvestrant treatment and cross-resistance between letrozole and exemestane. Int J Oncol. 2015;46:1481-90 pubmed 出版商
  • 免疫组化; 人类; 1:200
Liu J, Yu Y, Sun J, He S, Wang X, Yin J, et al. Clinicopathologic characteristics and prognosis of primary squamous cell carcinoma of the breast. Breast Cancer Res Treat. 2015;149:133-40 pubmed 出版商
  • 免疫组化; 人类; 1:300
Chan A, Tong J, Sung M, Lai P, To K. Epstein-Barr virus-associated lymphoepithelioma-like cholangiocarcinoma: a rare variant of intrahepatic cholangiocarcinoma with favourable outcome. Histopathology. 2014;65:674-83 pubmed 出版商
  • 免疫组化; 人类; 1:400
Kim E, Kim J, Lee Y, Chong G, Park J, Hong D. Comparison of estrogen receptor-?, progesterone receptor and calponin expression in gonadotrophin-releasing hormone agonist-sensitive and -resistant uterine fibroids. Obstet Gynecol Sci. 2014;57:144-50 pubmed 出版商
  • 免疫细胞化学; 人类; 1:25
  • 免疫组化; 人类; 1:25
Balk Møller E, Kim J, Hopkinson B, Timmermans Wielenga V, Petersen O, Villadsen R. A marker of endocrine receptor-positive cells, CEACAM6, is shared by two major classes of breast cancer: luminal and HER2-enriched. Am J Pathol. 2014;184:1198-208 pubmed 出版商
  • 免疫组化-石蜡切片; 人类; 1:2000
Liu Y, Nenutil R, Appleyard M, Murray K, Boylan M, Thompson A, et al. Lack of correlation of stem cell markers in breast cancer stem cells. Br J Cancer. 2014;110:2063-71 pubmed 出版商
  • 免疫组化; 小鼠; 1:1000-10000
von Figura G, Fukuda A, Roy N, Liku M, Morris Iv J, Kim G, et al. The chromatin regulator Brg1 suppresses formation of intraductal papillary mucinous neoplasm and pancreatic ductal adenocarcinoma. Nat Cell Biol. 2014;16:255-67 pubmed 出版商
  • 免疫组化; 人类
Dean S, Perks C, Holly J, Bhoo Pathy N, Looi L, Mohammed N, et al. Loss of PTEN expression is associated with IGFBP2 expression, younger age, and late stage in triple-negative breast cancer. Am J Clin Pathol. 2014;141:323-33 pubmed 出版商
  • 免疫印迹; 人类; 1:2000
Kirkegaard T, Hansen S, Larsen S, Reiter B, Sørensen B, Lykkesfeldt A. T47D breast cancer cells switch from ER/HER to HER/c-Src signaling upon acquiring resistance to the antiestrogen fulvestrant. Cancer Lett. 2014;344:90-100 pubmed 出版商
  • 免疫组化; 小鼠
  • 免疫印迹; 小鼠
Goddard L, Murphy T, Org T, Enciso J, HASHIMOTO PARTYKA M, Warren C, et al. Progesterone receptor in the vascular endothelium triggers physiological uterine permeability preimplantation. Cell. 2014;156:549-62 pubmed 出版商
  • 免疫组化; 人类; 1:100
Abdelzaher E, El Deeb N, Gowil A, Yehya A. Biological and demographic profile of meningiomas in a cohort of Egyptian patients: impact on tumor recurrence. ScientificWorldJournal. 2013;2013:375139 pubmed 出版商
  • 免疫组化-石蜡切片; 人类
  • 免疫细胞化学; 人类
Dong P, Kaneuchi M, Xiong Y, Cao L, Cai M, Liu X, et al. Identification of KLF17 as a novel epithelial to mesenchymal transition inducer via direct activation of TWIST1 in endometrioid endometrial cancer. Carcinogenesis. 2014;35:760-8 pubmed 出版商
  • 免疫组化; 人类
Hrstka R, Brychtova V, Fabian P, Vojtesek B, Svoboda M. AGR2 predicts tamoxifen resistance in postmenopausal breast cancer patients. Dis Markers. 2013;35:207-12 pubmed 出版商
  • 免疫印迹; 小鼠
Gagnidze K, Weil Z, Faustino L, Schaafsma S, Pfaff D. Early histone modifications in the ventromedial hypothalamus and preoptic area following oestradiol administration. J Neuroendocrinol. 2013;25:939-55 pubmed 出版商
  • 免疫印迹; 人类; 0.32 ug/ml
Bjerre C, Vinther L, Belling K, Würtz S, Yadav R, Lademann U, et al. TIMP1 overexpression mediates resistance of MCF-7 human breast cancer cells to fulvestrant and down-regulates progesterone receptor expression. Tumour Biol. 2013;34:3839-51 pubmed 出版商
  • 免疫组化-石蜡切片; 人类; 1:200; 图 2
Zhang J, Wang Y, Yin Q, Zhang W, Zhang T, Niu Y. An associated classification of triple negative breast cancer: the risk of relapse and the response to chemotherapy. Int J Clin Exp Pathol. 2013;6:1380-91 pubmed
  • 免疫组化; 人类
Fawzy M, Aly N, Shalaby S, El Sawy W, Abdul Maksoud R. Cyclooxygenase-2 169C>G and 8473T>C gene polymorphisms and prostaglandin E2 level in breast cancer: a case-control study. Gene. 2013;527:601-5 pubmed 出版商
  • 免疫组化; 人类; 1:250
Lai H, Tseng L, Chang T, Kuo Y, Hsieh C, Chen S, et al. The prognostic significance of metaplastic carcinoma of the breast (MCB)--a case controlled comparison study with infiltrating ductal carcinoma. Breast. 2013;22:968-73 pubmed 出版商
  • 染色质免疫沉淀 ; 人类; 3 ug
  • 免疫细胞化学; 人类; 1:400
  • 免疫印迹; 人类; 1:2000
Goddard L, Ton A, Org T, Mikkola H, Iruela Arispe M. Selective suppression of endothelial cytokine production by progesterone receptor. Vascul Pharmacol. 2013;59:36-43 pubmed 出版商
  • 免疫组化; 人类
Hao J, Yang C, Liu F, Yang Y, Li S, Li W, et al. Accessory breast cancer occurring concurrently with bilateral primary invasive breast carcinomas: a report of two cases and literature review. Cancer Biol Med. 2012;9:197-201 pubmed 出版商
  • 免疫组化; 人类; 1:1000
Gudlaugsson E, Klos J, Skaland I, Janssen E, Smaaland R, Feng W, et al. Prognostic comparison of the proliferation markers (mitotic activity index, phosphohistone H3, Ki67), steroid receptors, HER2, high molecular weight cytokeratins and classical prognostic factors in T???N?M? breast cancer. Pol J Pathol. 2013;64:1-8 pubmed
  • 免疫组化; 人类
Brouckaert O, Laenen A, Wildiers H, Floris G, Moerman P, Van Limbergen E, et al. The prognostic role of preoperative and (early) postoperatively change in CA15.3 serum levels in a single hospital cohort of primary operable breast cancers. Breast. 2013;22:254-62 pubmed 出版商
  • 免疫组化-石蜡切片; 人类; 1:100; 表 2
Joensuu K, Leidenius M, Kero M, Andersson L, Horwitz K, Heikkila P. ER, PR, HER2, Ki-67 and CK5 in Early and Late Relapsing Breast Cancer-Reduced CK5 Expression in Metastases. Breast Cancer (Auckl). 2013;7:23-34 pubmed 出版商
  • 免疫组化; 人类; 1:400
Makroo R, Chowdhry M, Kumar M, Srivastava P, Tyagi R, Bhadauria P, et al. Correlation between HER2 gene amplification and protein overexpression through fluorescence in situ hybridization and immunohistochemistry in breast carcinoma patients. Indian J Pathol Microbiol. 2012;55:481-4 pubmed 出版商
  • 免疫组化; 人类
Hashad D, Sorour A, Ghazal A, Talaat I. Free circulating tumor DNA as a diagnostic marker for breast cancer. J Clin Lab Anal. 2012;26:467-72 pubmed 出版商
  • 免疫组化; 人类; 1:500
Laliotis A, Vrekoussis T, Kafousi M, Sanidas E, Askoxilakis J, Melissas J, et al. Immunohistochemical study of pElk-1 expression in human breast cancer: association with breast cancer biologic profile and clinicopathologic features. Breast. 2013;22:89-95 pubmed 出版商
  • 免疫组化; 人类; 1:100
Masago K, Hosada W, Sasaki E, Murakami Y, Sugano M, Nagasaka T, et al. Is primary pulmonary meningioma a giant form of a meningothelial-like nodule? A case report and review of the literature. Case Rep Oncol. 2012;5:471-8 pubmed 出版商
  • 免疫组化; 人类; 1:500; 表 1
Escobar J, Klimowicz A, Dean M, Chu P, Nation J, Nelson G, et al. Quantification of ER/PR expression in ovarian low-grade serous carcinoma. Gynecol Oncol. 2013;128:371-6 pubmed 出版商
  • 免疫组化; 人类; 1:250
Yang L, Tseng H, Lin C, Chen L, Chen S, Kuo S, et al. Survival benefit of tamoxifen in estrogen receptor-negative and progesterone receptor-positive low grade breast cancer patients. J Breast Cancer. 2012;15:288-95 pubmed 出版商
  • 免疫组化; 人类; 1:200
Marian C, Boilă A, Soanca D, Malau M, Podeanu D, Resetkova E, et al. Malignant transformation of adenomyoepithelioma of the breast by a monophasic population: a report of two cases and review of literature. APMIS. 2013;121:272-9 pubmed 出版商
  • 免疫组化; 人类
Haltas H, Bayrak R, Yenidunya S, Kosehan D, Sen M, Akin K. Invasive lobular carcinoma with extracellular mucin as a distinct variant of lobular carcinoma: a case report. Diagn Pathol. 2012;7:91 pubmed 出版商
  • 免疫组化; 人类
Grell P, Fabian P, Khoylou M, Radova L, Slaby O, Hrstka R, et al. Akt expression and compartmentalization in prediction of clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumab. Int J Oncol. 2012;41:1204-12 pubmed 出版商
  • 免疫组化; 人类; 1:50
Tergas A, Buell Gutbrod R, Gwin K, Kocherginsky M, Temkin S, Fefferman A, et al. Clinico-pathologic comparison of type II endometrial cancers based on tamoxifen exposure. Gynecol Oncol. 2012;127:316-20 pubmed 出版商
  • 免疫组化; 人类; 1:50
Bonzanini M, Morelli L, Bonandini E, Leonardi E, Pertile R, Dalla Palma P. Cytologic features of triple-negative breast carcinoma. Cancer Cytopathol. 2012;120:401-9 pubmed 出版商
  • 免疫组化; 人类; 1:1000
Jonsdottir K, Zhang H, Jhagroe D, Skaland I, Slewa A, Björkblom B, et al. The prognostic value of MARCKS-like 1 in lymph node-negative breast cancer. Breast Cancer Res Treat. 2012;135:381-90 pubmed 出版商
  • 免疫组化; 人类; 1:200
Iqbal J, Thike A, Cheok P, Tse G, Tan P. Insulin growth factor receptor-1 expression and loss of PTEN protein predict early recurrence in triple-negative breast cancer. Histopathology. 2012;61:652-9 pubmed 出版商
  • 免疫组化; 人类
Brouckaert O, Laenen A, Vanderhaegen J, Wildiers H, Leunen K, Amant F, et al. Applying the 2011 St Gallen panel of prognostic markers on a large single hospital cohort of consecutively treated primary operable breast cancers. Ann Oncol. 2012;23:2578-84 pubmed
  • 免疫组化; 人类
Svoboda M, Sana J, Redova M, Navratil J, Palacova M, Fabian P, et al. MiR-34b is associated with clinical outcome in triple-negative breast cancer patients. Diagn Pathol. 2012;7:31 pubmed 出版商
  • 免疫组化; 人类
Zheng S, Bai J, Li J, Fan J, Pang Y, Song Q, et al. The pathologic characteristics of breast cancer in China and its shift during 1999-2008: a national-wide multicenter cross-sectional image over 10 years. Int J Cancer. 2012;131:2622-31 pubmed 出版商
  • 免疫组化; 人类
Yigit S, Pehlivan F, Evcim G, Etit D. Clinicopathologic features of the mixed epithelial and mesenchymal type metaplastic breast carcinoma with myoepithelial differentiation in a subset of six cases. Pathol Res Pract. 2012;208:147-50 pubmed 出版商
  • 免疫组化; 人类; 1:250
Lin C, Chen D, Chang K, Chang T, Wang H. A phase II study of neoadjuvant chemotherapy with docetaxel, cisplatin and trastuzumab for T2 breast cancers. Cancer Chemother Pharmacol. 2012;69:1363-8 pubmed 出版商
  • 免疫组化; 人类; 1:100
Bozkurt K, Kapucuoglu N. Investigation of immunohistochemical ER?, ER? and ER?cx expressions in normal and neoplastic breast tissues. Pathol Res Pract. 2012;208:133-9 pubmed 出版商
  • 免疫组化; 人类; 1:250
Lin C, Chien S, Kuo S, Chen L, Chen S, Lai H, et al. A 10-year follow-up of triple-negative breast cancer patients in Taiwan. Jpn J Clin Oncol. 2012;42:161-7 pubmed 出版商
  • 免疫组化; 人类
Bolat F, Canpolat T, Tarim E. Pregnancy-related peritoneal ectopic decidua (deciduosis): morphological and clinical evaluation. Turk Patoloji Derg. 2012;28:56-60 pubmed 出版商
  • 免疫组化; 人类; 1:250
Chen S, Lai H, Tseng H, Chen L, Kuo S, Chen D. Correlation of histologic grade with other clinicopathological parameters, intrinsic subtype, and patients' clinical outcome in Taiwanese women. Jpn J Clin Oncol. 2011;41:1327-35 pubmed 出版商
  • 免疫组化; 人类; 1:200
El Gendi S, Mostafa M, El Gendi A. Stromal caveolin-1 expression in breast carcinoma. Correlation with early tumor recurrence and clinical outcome. Pathol Oncol Res. 2012;18:459-69 pubmed 出版商
  • 免疫组化-石蜡切片; 犬; 1:200
Chu P, Hsu N, Liao A, Shih N, Hou M, Liu C. Overexpression of ?-enolase correlates with poor survival in canine mammary carcinoma. BMC Vet Res. 2011;7:62 pubmed 出版商
  • 免疫组化; 人类
Ramadan S, Yapicier O, Kıhtır S, Erdemir A, Doğan T, Uskent I, et al. Correlation of HER 2/neu gene amplification with immunohistochemistry and other prognostic factors in breast carcinoma. Turk Patoloji Derg. 2011;27:196-203 pubmed 出版商
  • 免疫组化; 人类; 1:50
Ulasov I, Kaverina N, Pytel P, Thaci B, Liu F, Hurst D, et al. Clinical significance of KISS1 protein expression for brain invasion and metastasis. Cancer. 2012;118:2096-105 pubmed 出版商
  • 免疫组化; 人类
Keskin S, Muslumanoglu M, Saip P, Karanlik H, Guveli M, Pehlivan E, et al. Clinical and pathological features of breast cancer associated with the pathological complete response to anthracycline-based neoadjuvant chemotherapy. Oncology. 2011;81:30-8 pubmed 出版商
  • 免疫组化; 人类; 1:200
Singh A, Mishra A, Ylaya K, Hewitt S, Sharma K, Saxena S. Wilms tumor-1, claudin-1 and ezrin are useful immunohistochemical markers that help to distinguish schwannoma from fibroblastic meningioma. Pathol Oncol Res. 2012;18:383-9 pubmed 出版商
  • 免疫组化; 小鼠; 1:200
  • 免疫印迹; 小鼠; 1:500
Heijmans J, Muncan V, Jacobs R, de Jonge Muller E, Graven L, Biemond I, et al. Intestinal tumorigenesis is not affected by progesterone signaling in rodent models. PLoS ONE. 2011;6:e22620 pubmed 出版商
  • 免疫组化; 人类
Sun H, Zheng Y, Ou W, Fang Q, Li P, Ye X, et al. Association between hormone receptor expression and epidermal growth factor receptor mutation in patients operated on for non-small cell lung cancer. Ann Thorac Surg. 2011;91:1562-7 pubmed 出版商
  • 免疫组化; 小鼠; 1:200; 图 1
Meyer D, Brinkhaus H, Müller U, Muller M, Cardiff R, Bentires Alj M. Luminal expression of PIK3CA mutant H1047R in the mammary gland induces heterogeneous tumors. Cancer Res. 2011;71:4344-51 pubmed 出版商
  • 免疫组化-石蜡切片; 人类; 1:200
Teng Y, Tan W, Thike A, Cheok P, Tse G, Wong N, et al. Mutations in the epidermal growth factor receptor (EGFR) gene in triple negative breast cancer: possible implications for targeted therapy. Breast Cancer Res. 2011;13:R35 pubmed 出版商
  • 免疫组化; 人类; 1:100
Guan B, Wang H, Cao S, Rao Q, Wang Y, Zhu Y, et al. Lipid-rich carcinoma of the breast clinicopathologic analysis of 17 cases. Ann Diagn Pathol. 2011;15:225-32 pubmed 出版商
  • 免疫组化; 犬; 1:40
Bartel C, Berghold P, Walter I. Ectopic endometrial tissue in mesonephric duct remnants in bitches. Reprod Domest Anim. 2011;46:950-6 pubmed 出版商
  • 免疫组化; 人类; 1:100
Chuah B, Putti T, Salto Tellez M, Charlton A, Iau P, Buhari S, et al. Serial changes in the expression of breast cancer-related proteins in response to neoadjuvant chemotherapy. Ann Oncol. 2011;22:1748-54 pubmed 出版商
  • 免疫组化; 人类; 1:1000
Gudlaugsson E, Skaland I, Undersrud E, Janssen E, Søiland H, Baak J. D2-40/p63 defined lymph vessel invasion has additional prognostic value in highly proliferating operable node negative breast cancer patients. Mod Pathol. 2011;24:502-11 pubmed 出版商
  • 免疫组化; 人类; 1:300
Ege C, Akbulut M, Zekioglu O, Ozdemir N. Investigation of galectin-3 and heparanase in endometrioid and serous carcinomas of the endometrium and correlation with known predictors of survival. Arch Gynecol Obstet. 2011;284:1231-9 pubmed 出版商
  • 免疫组化; 人类; 1:250
Lai H, Kuo S, Chen L, Chi C, Chen S, Chang T, et al. Prognostic significance of triple negative breast cancer at tumor size 1 cm and smaller. Eur J Surg Oncol. 2011;37:18-24 pubmed 出版商
  • 免疫组化; 人类
Kosemehmetoglu K, Guler G. Papillary apocrine metaplasia and columnar cell lesion with atypia: is there a shared common pathway?. Ann Diagn Pathol. 2010;14:425-31 pubmed 出版商
  • 免疫组化; 人类; 1:1
Abdelzaher E, El Gendi S, Yehya A, Gowil A. Recurrence of benign meningiomas: predictive value of proliferative index, BCL2, p53, hormonal receptors and HER2 expression. Br J Neurosurg. 2011;25:707-13 pubmed 出版商
  • 免疫组化; 人类
Rhodes A, Sarson J, Assam E, Dean S, Cribb E, Parker A. The reliability of rabbit monoclonal antibodies in the immunohistochemical assessment of estrogen receptors, progesterone receptors, and HER2 in human breast carcinomas. Am J Clin Pathol. 2010;134:621-32 pubmed 出版商
  • 免疫组化; 人类; 1:200
Lwin Z, Guo C, Salim A, Yip G, Chew F, Nan J, et al. Clinicopathological significance of calreticulin in breast invasive ductal carcinoma. Mod Pathol. 2010;23:1559-66 pubmed 出版商
  • 免疫印迹; 人类; 1:1000
Janssen E, Slewa A, Gudlaugsson E, Jonsdottir K, Skaland I, Søiland H, et al. Biologic profiling of lymph node negative breast cancers by means of microRNA expression. Mod Pathol. 2010;23:1567-76 pubmed 出版商
  • 免疫组化; 人类; 1:200
Giordano G, Lombardi M, Brigati F, Mancini C, Silini E. Clinicopathologic features of 2 new cases of uterine tumors resembling ovarian sex cord tumors. Int J Gynecol Pathol. 2010;29:459-67 pubmed 出版商
  • 免疫组化; 人类; 1:200
Chen C, Xia H, Gong Y, Peng J, Peng C, Hu M, et al. The quantitative detection of total HER2 load by quantum dots and the identification of a new subtype of breast cancer with different 5-year prognosis. Biomaterials. 2010;31:8818-25 pubmed 出版商
  • 免疫组化-石蜡切片; 人类; 1:250; 图 2, 3, 4
  • 免疫组化; 人类; 1:250
Baydar D, Kulac I, Gurel B, De Marzo A. A case of prostatic adenocarcinoma with aberrant p63 expression: presentation with detailed immunohistochemical study and FISH analysis. Int J Surg Pathol. 2011;19:131-6 pubmed 出版商
  • 免疫细胞化学; 人类; 1:150
  • 免疫组化; 人类; 1:150
Bohn O, Fuertes Camilo M, Navarro L, Saldivar J, Sanchez Sosa S. p16INK4a expression in basal-like breast carcinoma. Int J Clin Exp Pathol. 2010;3:600-7 pubmed
  • 免疫组化; 人类; 1:400
Alkushi A, Köbel M, Kalloger S, Gilks C. High-grade endometrial carcinoma: serous and grade 3 endometrioid carcinomas have different immunophenotypes and outcomes. Int J Gynecol Pathol. 2010;29:343-50 pubmed 出版商
  • 免疫组化; 人类; 1:25
de Neergaard M, Kim J, Villadsen R, Fridriksdottir A, Rank F, Timmermans Wielenga V, et al. Epithelial-stromal interaction 1 (EPSTI1) substitutes for peritumoral fibroblasts in the tumor microenvironment. Am J Pathol. 2010;176:1229-40 pubmed 出版商
  • 免疫组化; 人类; 1:100
Wang H, Guan B, Shi Q, Ma H, Zhou H, Wang X, et al. May metaplastic breast carcinomas be actually basal-like carcinoma? Further evidence study with its ultrastructure and survival analysis. Med Oncol. 2011;28:42-50 pubmed 出版商
  • 免疫组化; 犬; 1:40
Bartel C, Schönkypl S, Walter I. Pseudo-placentational endometrial cysts in a bitch. Anat Histol Embryol. 2010;39:74-80 pubmed 出版商
  • 免疫组化; 人类; 1:200
Thike A, Cheok P, Jara Lazaro A, Tan B, Tan P, Tan P. Triple-negative breast cancer: clinicopathological characteristics and relationship with basal-like breast cancer. Mod Pathol. 2010;23:123-33 pubmed 出版商
  • 免疫组化; 人类
Chen H, Huang H, Li C, Ko S, Changchien C, Chen W, et al. Synchronous presentation of uterine leiomyosarcoma and retroperitoneal liposarcoma: analysis by comparative genomic hybridization and review of the literature. Int J Gynecol Pathol. 2009;28:535-40 pubmed 出版商
  • 免疫组化; 人类; 1:500
Celestino R, Magalhães J, Castro P, Triller M, Vinagre J, Soares P, et al. A follicular variant of papillary thyroid carcinoma in struma ovarii. Case report with unique molecular alterations. Histopathology. 2009;55:482-7 pubmed 出版商
  • 免疫组化; 人类; 1:75
Raso M, Behrens C, Herynk M, Liu S, Prudkin L, Ozburn N, et al. Immunohistochemical expression of estrogen and progesterone receptors identifies a subset of NSCLCs and correlates with EGFR mutation. Clin Cancer Res. 2009;15:5359-68 pubmed 出版商
  • 免疫印迹; 人类
Rao A, Ziegler Y, McLeod I, Yates J, Nardulli A. Thioredoxin and thioredoxin reductase influence estrogen receptor alpha-mediated gene expression in human breast cancer cells. J Mol Endocrinol. 2009;43:251-61 pubmed 出版商
  • 免疫组化; 人类
Wang L, Jiang Z, Sui M, Shen J, Xu C, Fan W. The potential biomarkers in predicting pathologic response of breast cancer to three different chemotherapy regimens: a case control study. BMC Cancer. 2009;9:226 pubmed 出版商
  • 免疫组化; 人类; 1:200
Locati L, Perrone F, Losa M, Mela M, Casieri P, Orsenigo M, et al. Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs). Oral Oncol. 2009;45:986-90 pubmed 出版商
  • 免疫印迹; 人类; 1:250
Lin C, Chien S, Chen L, Kuo S, Chang T, Chen D. Triple negative breast carcinoma is a prognostic factor in Taiwanese women. BMC Cancer. 2009;9:192 pubmed 出版商
  • 免疫组化; 人类; 1:300
Rocha R, Nunes C, Sanches F, Rocha G, Oliveira F, Reis Filho J, et al. Rabbit antibodies for hormone receptors and HER2 evaluation in breast cancer. Rev Assoc Med Bras (1992). 2009;55:163-8 pubmed
  • 免疫组化; 人类; 1:200
Snyder E, Bailey D, Shipitsin M, Polyak K, Loda M. Identification of CD44v6(+)/CD24- breast carcinoma cells in primary human tumors by quantum dot-conjugated antibodies. Lab Invest. 2009;89:857-66 pubmed 出版商
  • 免疫印迹; 人类
Curtis C, Thorngren D, Ziegler Y, Sarkeshik A, Yates J, Nardulli A. Apurinic/apyrimidinic endonuclease 1 alters estrogen receptor activity and estrogen-responsive gene expression. Mol Endocrinol. 2009;23:1346-59 pubmed 出版商
  • 免疫组化; 人类; 1:50
Blance R, Sims A, Anderson E, Howell A, Clarke R. Normal breast tissue implanted into athymic nude mice identifies biomarkers of the effects of human pregnancy levels of estrogen. Cancer Prev Res (Phila). 2009;2:257-64 pubmed 出版商
  • 免疫组化; 人类; 1:200
Tezel G, Uner A, Yildiz I, Guler G, Takahashi M. RET finger protein expression in invasive breast carcinoma: relationship between RFP and ErbB2 expression. Pathol Res Pract. 2009;205:403-8 pubmed 出版商
  • 免疫组化; 人类; 1:400
Hanley K, Siddiqui M, Lawson D, Cohen C, Nassar A. Evaluation of new monoclonal antibodies in detection of estrogen receptor, progesterone receptor, and Her2 protein expression in breast carcinoma cell block sections using conventional microscopy and quantitative image analysis. Diagn Cytopathol. 2009;37:251-7 pubmed 出版商
  • 免疫组化; 人类; 1:400
Søiland H, Skaland I, Varhaug J, Kørner H, Janssen E, Gudlaugsson E, et al. Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer--possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients. Acta Oncol. 2009;48:514-21 pubmed 出版商
  • 免疫组化; 犬; 1:100
Stadler K, Handler J, Schoenkypl S, Walter I. A three-dimensional culture model of canine uterine glands. In Vitro Cell Dev Biol Anim. 2009;45:35-43 pubmed 出版商
  • 免疫组化; 人类; 1:400
Søiland H, Kørner H, Skaland I, Janssen E, Gudlaugsson E, Varhaug J, et al. Prognostic relevance of androgen receptor detection in operable breast cancer. J Surg Oncol. 2008;98:551-8 pubmed 出版商
  • 免疫组化; 人类; 1:300
Rocha R, Nunes C, Rocha G, Oliveira F, Sanches F, Gobbi H. Rabbit monoclonal antibodies show higher sensitivity than mouse monoclonals for estrogen and progesterone receptor evaluation in breast cancer by immunohistochemistry. Pathol Res Pract. 2008;204:655-62 pubmed 出版商
  • 免疫组化; 人类
Horwitz K, Dye W, Harrell J, Kabos P, Sartorius C. Rare steroid receptor-negative basal-like tumorigenic cells in luminal subtype human breast cancer xenografts. Proc Natl Acad Sci U S A. 2008;105:5774-9 pubmed 出版商
  • 免疫组化; 人类
Kaya H, Bozkurt S, Erbarut I, Djamgoz M. Apocrine carcinomas of the breast in Turkish women: hormone receptors, c-erbB-2 and p53 immunoexpression. Pathol Res Pract. 2008;204:367-71 pubmed 出版商
  • 免疫组化; 人类
Van Calster B, Vanden Bempt I, Drijkoningen M, Pochet N, Cheng J, Van Huffel S, et al. Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive. Breast Cancer Res Treat. 2009;113:181-7 pubmed 出版商
  • 免疫组化; 人类; 1:500
De Maeyer L, Van Limbergen E, De Nys K, Moerman P, Pochet N, Hendrickx W, et al. Does estrogen receptor negative/progesterone receptor positive breast carcinoma exist?. J Clin Oncol. 2008;26:335-6; author reply 336-8 pubmed 出版商
  • 免疫组化; 人类
Eroglu A, Sari A. Expression of c-kit proto-oncogene product in breast cancer tissues. Med Oncol. 2007;24:169-74 pubmed
  • 免疫组化; 小鼠; 1:100
Girling J, Lederman F, Walter L, Rogers P. Progesterone, but not estrogen, stimulates vessel maturation in the mouse endometrium. Endocrinology. 2007;148:5433-41 pubmed
  • 免疫组化; 人类
Neven P, Van Calster B, Van den Bempt I, Van Huffel S, Van Belle V, Hendrickx W, et al. Age interacts with the expression of steroid and HER-2 receptors in operable invasive breast cancer. Breast Cancer Res Treat. 2008;110:153-9 pubmed
  • 免疫组化; 人类; 1:500
Verlinden L, Vanden Bempt I, Eelen G, Drijkoningen M, Verlinden I, Marchal K, et al. The E2F-regulated gene Chk1 is highly expressed in triple-negative estrogen receptor /progesterone receptor /HER-2 breast carcinomas. Cancer Res. 2007;67:6574-81 pubmed
  • 免疫组化; 人类; 1:70
Wong S, Chan J, Lo E, Chan A, Wong M, Chan C, et al. The contribution of bifunctional SkipDewax pretreatment solution, rabbit monoclonal antibodies, and polymer detection systems in immunohistochemistry. Arch Pathol Lab Med. 2007;131:1047-55 pubmed
  • 免疫组化; 人类; 1:200
Giordano G, D Adda T, Gnetti L, Merisio C, Raboni S. Transitional cell carcinoma of the endometrium associated with benign ovarian brenner tumor: a case report with immunohistochemistry molecular analysis and a review of the literature. Int J Gynecol Pathol. 2007;26:298-304 pubmed
  • 免疫组化; 人类; 1:600
Decock J, Hendrickx W, Drijkoningen M, Wildiers H, Neven P, Smeets A, et al. Matrix metalloproteinase expression patterns in luminal A type breast carcinomas. Dis Markers. 2007;23:189-96 pubmed
  • 免疫组化; 人类; 1:200
Giordano G, D Adda T, Gnetti L, Merisio C, Gabrielli M, Melpignano M. Villoglandular adenocarcinoma of the cervix: two new cases with morphological and molecular study. Int J Gynecol Pathol. 2007;26:199-204 pubmed
  • 免疫组化; 人类
Nadasi E, Anga B, Sandor J, Megyesi J, Kelemen D, Mottolese M, et al. Prognostic factors in Hungarian breast cancer patients. Anticancer Res. 2007;27:279-82 pubmed
  • 免疫组化; 人类; 1:100
Kapucuoglu N, Aktepe F, Kaya H, Bircan S, Karahan N, Ciris M. Immunohistochemical expression of PTEN in normal, hyperplastic and malignant endometrium and its correlation with hormone receptors, bcl-2, bax, and apoptotic index. Pathol Res Pract. 2007;203:153-62 pubmed
  • 免疫印迹; 人类
Rasmussen L, Zaveri N, Stenvang J, Peters R, Lykkesfeldt A. A novel dual-target steroid sulfatase inhibitor and antiestrogen: SR 16157, a promising agent for the therapy of breast cancer. Breast Cancer Res Treat. 2007;106:191-203 pubmed
  • 免疫组化; 人类; 1:300
  • 免疫印迹; 人类; 1:300
  • 免疫组化; 小鼠; 1:300
  • 免疫印迹; 小鼠; 1:300
Teilmann S, Clement C, Thorup J, Byskov A, Christensen S. Expression and localization of the progesterone receptor in mouse and human reproductive organs. J Endocrinol. 2006;191:525-35 pubmed
  • 免疫组化; 人类; 1:400
Wiseman S, Masoudi H, Niblock P, Turbin D, Rajput A, Hay J, et al. Anaplastic thyroid carcinoma: expression profile of targets for therapy offers new insights for disease treatment. Ann Surg Oncol. 2007;14:719-29 pubmed
  • 免疫组化; 人类; 1:200
Sabah M, Mohan P, Kay E. Para-testicular cellular angiofibroma: a rare tumour in a male renal transplant patient. Virchows Arch. 2006;449:489-92 pubmed
  • 免疫组化; 人类
Goh B, Tan Y, Kumarasinghe M, Ooi L. Mucinous cystic tumor of the pancreas with ovarian-like mesenchymal stroma in a male patient. Dig Dis Sci. 2005;50:2170-7 pubmed
  • 免疫组化; 人类
Hascalik S, Celik O, Erdem G, Usta U, Alkan A, Karakas H, et al. Synchronous endometrial and cervical tumors in a 26-year-old nullipara: diagnostic modalities updated. Gynecol Obstet Invest. 2005;60:171-6 pubmed
  • 免疫印迹; 人类; 1:2000
Sonne Hansen K, Lykkesfeldt A. Endogenous aromatization of testosterone results in growth stimulation of the human MCF-7 breast cancer cell line. J Steroid Biochem Mol Biol. 2005;93:25-34 pubmed
  • 免疫组化; 人类; 1:200
Giordano G, D Adda T, Merisio C, Gnetti L. Primary squamous cell carcinoma of the endometrium: a case report with immunohistochemical and molecular study. Gynecol Oncol. 2005;96:876-9 pubmed
Kawaguchi K, Akeda K, Takegami N, Kurata T, Toriyabe K, Ikeda T, et al. Cervical schwannoma in the early stage of pregnancy: a case report. BMC Surg. 2020;20:245 pubmed 出版商
Guo S, Zhang C, Mottamal M, Hossain A, Liu J, Wang G. GLL398, an oral selective estrogen receptor degrader (SERD), blocks tumor growth in xenograft breast cancer models. Breast Cancer Res Treat. 2020;180:359-368 pubmed 出版商
Heuerman A, Hollinger T, Menon R, Mesiano S, Yellon S. Cervix Stromal Cells and the Progesterone Receptor A Isoform Mediate Effects of Progesterone for Prepartum Remodeling. Reprod Sci. 2019;26:690-696 pubmed 出版商
Ni N, Gao Y, Fang X, Melgar M, Vincent D, Lydon J, et al. Glandular defects in the mouse uterus with sustained activation of TGF-beta signaling is associated with altered differentiation of endometrial stromal cells and formation of stromal compartment. PLoS ONE. 2018;13:e0209417 pubmed 出版商
Wuidart A, Sifrim A, Fioramonti M, Matsumura S, Brisebarre A, Brown D, et al. Early lineage segregation of multipotent embryonic mammary gland progenitors. Nat Cell Biol. 2018;20:666-676 pubmed 出版商
Wang P, Wu S, Brooks K, Kelleher A, Milano Foster J, DeMayo F, et al. Generation of Mouse for Conditional Expression of Forkhead Box A2. Endocrinology. 2018;159:1897-1909 pubmed 出版商
Liang Y, Liu L, Jin Z, Liang X, Fu Y, Gu X, et al. The high concentration of progesterone is harmful for endometrial receptivity and decidualization. Sci Rep. 2018;8:712 pubmed 出版商
Nguyen D, Ouyang H, Mao J, Hlatky L, Barcellos Hoff M. Distinct luminal-type mammary carcinomas arise from orthotopic Trp53-null mammary transplantation of juvenile versus adult mice. Cancer Res. 2014;74:7149-58 pubmed 出版商
Meier Abt F, Brinkhaus H, Bentires Alj M. Early but not late pregnancy induces lifelong reductions in the proportion of mammary progesterone sensing cells and epithelial Wnt signaling. Breast Cancer Res. 2014;16:402 pubmed
Meier Abt F, Milani E, Roloff T, Brinkhaus H, Duss S, Meyer D, et al. Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium. Breast Cancer Res. 2013;15:R36 pubmed 出版商
图像
图像 1 :
赛默飞世尔 MA5-14505 图像 1
Formalin-fixed, paraffin-embedded human breast carcinoma stained with Progesterone Receptor using peroxidase-conjugate and DAB. Note strong nuclear staining of tumor cells.
图像 2 :
赛默飞世尔 MA5-14505 图像 2
产品信息
产品类型 :
抗体
产品名称 :
孕酮受体单克隆抗体(SP2)
目录# :
MA5-14505
规格 :
500微升
价格 :
美国792.00
克隆性 :
单克隆
纯度 :
蛋白质A
宿主 :
反应物种 :
人类, 大鼠
应用 :
Flow Cytometry: 1:100, Immunocytochemistry: 1:100, Immunohistochemistry (Paraffin): 1:400, Western Blot: 1:1,000-1:2,000
物种 :
人类, 大鼠
克隆 :
SP2
抗体亚型 :
IgG
储存 :
-20° C, Avoid Freeze/Thaw Cycles, store in dark
描述 :
The progesterone receptor (PR) is a member of the steroid family of nuclear receptors. The PR mediates the physiological effects of progesterone, which plays a central role in reproductive events associated with the establishment and maintenance of pregnancy. PR is found as a 94 kDa protein (Form A) or a 120 kDa protein (Form B) due to the use of alternative translation initiation sites. PR-B is the transcriptionally active form and is responsible for activating genes for the maintenance of the endometrium, maintenance of pregnancy, and inhibition of ovulation. PR-A is identical to PR-B except for a 165 amino acid deletion at the N-terminus. This deletion exposes a 140 amino acid inhibitory domain (ID) that acts as a repressor of steroid hormone transcriptional activity. In its inactive state, PgR forms a multiprotein complex which includes heat shock proteins and immunophins. Upon binding of progesterone hormone to its receptor, there is a conformational change that allows dimerization and binding of the receptor to progesterone response elements (PRE) sequences, resulting in activated transcription. A Null mutation in the PGR gene leads to pleiotrophic reproductive abnormalities.
免疫原 :
Recombinant protein encoding human progesterone receptor 412-526 aa
格式 :
液体
应用w/稀释 :
Flow Cytometry: 1:100, Immunocytochemistry: 1:100, Immunohistochemistry (Paraffin): 1:400, Western Blot: 1:1,000-1:2,000
别名 :
9930019P03Rik; BB114106; ENSMUSG00000074510; LOW QUALITY PROTEIN: progesterone receptor; NR3C3; Nuclear receptor subfamily 3 group C member 3; p4 receptor; PGR; pot. alt. progesterone receptor; putative; PR; PR-A; PR-B; Progesterone receptor; progesterone receptor A; progesterone-receptor; putative form B; steroid hormone receptor; testicular progesterone receptor; unnamed protein product
更多信息或购买 :
公司信息
赛默飞世尔
上海浦东新金桥路27号7号楼
analyze.cn@thermofisher.com
http://www.thermo.com.cn
1084193588
公司总部: 美国